China

China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data
Fierce Pharma
CanSino Biotech
China
clinical trials
vaccines
COVID-19
Flag link:
FDA's Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic
FDA's Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic
Fierce Pharma
China
FDA
Stephen Hahn
COVID-19
Flag link:
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
JNJ
Janssen
China
drug manufacturing
Flag link:
Hydroxychloroquine Is Ineffective In Treatment Of Patients Hospitalized With Covid-19, According To Small Controlled Trial From Shanghai
Hydroxychloroquine Is Ineffective In Treatment Of Patients Hospitalized With Covid-19, According To Small Controlled Trial From Shanghai
Forbes
China
clinical trials
COVID-19
hydroxychloroquine
coronaviruses
Flag link:
Coronavirus: Woman accused of hiding COVID-19 symptoms while flying to China is former Biogen employee
Coronavirus: Woman accused of hiding COVID-19 symptoms while flying to China is former Biogen employee
Mass Live
China
Biogen
COVID-19
coronaviruses
Flag link:
Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials Say
Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials Say
Forbes
COVID-19
Japan
China
favipiravir
Avigan
Fujifilm Toyama
clinical trials
Flag link:
Sanofi joins parade of drugmakers pledging no COVID-19 shortages
Sanofi joins parade of drugmakers pledging no COVID-19 shortages
Fierce Pharma
drug shortages
Sanofi
China
COVID-19
Flag link:
With weeks to go to COVID-19 vaccine trial, BioNTech lands $135M deal and advances Pfizer talks
With weeks to go to COVID-19 vaccine trial, BioNTech lands $135M deal and advances Pfizer talks
Fierce Biotech
BioNTech
Pfizer
China
vaccines
coronaviruses
COVID-19
Flag link:
How much does U.S. rely on China for drugs? FDA simply doesn't know
How much does U.S. rely on China for drugs? FDA simply doesn't know
Fierce Pharma
China
APIs
supply chain
COVID-19
coronaviruses
Flag link:
Coronavirus Spurs U.S. Efforts to End China’s Chokehold on Drugs
Coronavirus Spurs U.S. Efforts to End China’s Chokehold on Drugs
NY Times, NY
China
supply chain
coronaviruses
COVID-19
Flag link:
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
Endpoints
CAR-T
IPOs
GenScript
CROs
China
JNJ
Flag link:
New coronavirus maps offer insights for detection and treatment
New coronavirus maps offer insights for detection and treatment
Fierce Biotech
COVID-19
coronaviruses
China
enzymes
Flag link:
China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines
China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines
Fierce Pharma
Roche
China
COVID-19
coronaviruses
Actemra
Flag link:
Coronavirus Hits Big Medtech Where It Hurts Most – Revenue
Coronavirus Hits Big Medtech Where It Hurts Most – Revenue
Medical Devices and Diagnostics Industry
China
coronaviruses
COVID-19
devices
Flag link:
FDA Monitoring 20 Drugs at Risk of Shortage due to Coronavirus
FDA Monitoring 20 Drugs at Risk of Shortage due to Coronavirus
RAPS.org
China
FDA
coronaviruses
COVID-19
drug shortages
APIs
Flag link:
Harvard joins coronavirus fight with $115M and a high-profile Chinese partner
Harvard joins coronavirus fight with $115M and a high-profile Chinese partner
Endpoints
Harvard
China
Guangzhou Institute
COVID-19
Flag link:
Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official
Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official
Motley Fool
Gilead Sciences
coronavirus
COVID-19
WHO
antivirals
China
remdesivir
Flag link:
Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages
Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages
Stat
Sanofi
spinoffs
drug manufacturing
APIs
China
India
drug shortages
Flag link:
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
Stat
China
GSK
vaccines
coronavirus
Clover BioPharmaceuticals
Flag link:
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Pharmaforum
China
Gilead Sciences
Sovaldi
COVID-19
coronaviruses
Flag link:

Pages